MDR.ASX: Reinstatement to Official Quotation

Reinstatement to Official Quotation

Stock	Medadvisor Ltd (MDR.ASX)
Release Time	2 May 2025, 5:58 p.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

MedAdvisor Ltd Reinstated to Official Quotation

Key Points

Trading suspension lifted following announcement of court application outcome
Announcement made under section 1322 of Corporations Act 2001
Shares to resume trading immediately

Full Summary

MedAdvisor Ltd (ASX: MDR) has been reinstated to official quotation on the Australian Securities Exchange (ASX) following the release of an announcement regarding the outcome of a court application under section 1322 of the Corporations Act 2001 (Cth). The suspension of trading in MedAdvisor's securities will be lifted immediately after the company's announcement. Section 1322 of the Corporations Act provides a mechanism for the court to make orders to rectify any procedural irregularities or technical non-compliance with the Act. The details of MedAdvisor's court application and its outcome have not been disclosed in the ASX announcement. However, the reinstatement to official quotation indicates that the issue has been resolved, allowing the company's shares to resume trading on the ASX.